Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Cell line | Mutation details | Probe for labeling this protein in this cell | |||
---|---|---|---|---|---|
A431 | SNV: p.P439T | DBIA Probe Info | |||
HT115 | SNV: p.H343Y | . | |||
MCC13 | SNV: p.L440F | . | |||
NCIH1155 | Deletion: p.P108LfsTer10 | DBIA Probe Info |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
Probe 1 Probe Info |
![]() |
Y86(91.02); Y100(13.25) | LDD3495 | [1] | |
BTD Probe Info |
![]() |
C425(1.19) | LDD1700 | [2] | |
DBIA Probe Info |
![]() |
C45(1.04); C327(1.00) | LDD0078 | [3] | |
5E-2FA Probe Info |
![]() |
H102(0.00); H395(0.00); H32(0.00) | LDD2235 | [4] | |
m-APA Probe Info |
![]() |
H395(0.00); H32(0.00); H102(0.00); H445(0.00) | LDD2231 | [4] | |
IA-alkyne Probe Info |
![]() |
C45(0.00); C22(0.00); C425(0.00); C401(0.00) | LDD0162 | [5] | |
IPM Probe Info |
![]() |
N.A. | LDD0025 | [6] | |
WYneN Probe Info |
![]() |
N.A. | LDD0021 | [7] | |
TFBX Probe Info |
![]() |
C327(0.00); C45(0.00); C22(0.00) | LDD0148 | [6] | |
Acrolein Probe Info |
![]() |
H32(0.00); H445(0.00); H395(0.00); C327(0.00) | LDD0217 | [8] | |
Crotonaldehyde Probe Info |
![]() |
N.A. | LDD0219 | [8] | |
Methacrolein Probe Info |
![]() |
C327(0.00); C45(0.00); C22(0.00) | LDD0218 | [8] | |
NAIA_5 Probe Info |
![]() |
C22(0.00); C45(0.00); C327(0.00); C401(0.00) | LDD2223 | [9] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DA-2 Probe Info |
![]() |
N.A. | LDD0072 | [10] | |
STS-1 Probe Info |
![]() |
N.A. | LDD0068 | [11] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0524 | 2-Cyano-N-(2-morpholin-4-yl-ethyl)-acetamide | MDA-MB-231 | C425(0.95) | LDD2117 | [2] |
LDCM0020 | ARS-1620 | HCC44 | C45(1.04); C327(1.00) | LDD0078 | [3] |
LDCM0108 | Chloroacetamide | HeLa | H445(0.00); C327(0.00); C425(0.00); C22(0.00) | LDD0222 | [8] |
LDCM0632 | CL-Sc | Hep-G2 | C327(0.52) | LDD2227 | [9] |
LDCM0107 | IAA | HeLa | H445(0.00); H32(0.00); H395(0.00); H308(0.00) | LDD0221 | [8] |
LDCM0022 | KB02 | 769-P | C45(1.17); C327(1.12) | LDD2246 | [12] |
LDCM0023 | KB03 | 769-P | C45(1.51); C327(1.38) | LDD2663 | [12] |
LDCM0024 | KB05 | HMCB | C327(1.47) | LDD3312 | [12] |
LDCM0109 | NEM | HeLa | H445(0.00); H32(0.00); H395(0.00); H23(0.00) | LDD0223 | [8] |
LDCM0506 | Nucleophilic fragment 16a | MDA-MB-231 | C425(0.64) | LDD2099 | [2] |
LDCM0516 | Nucleophilic fragment 21a | MDA-MB-231 | C425(0.68); C22(0.53) | LDD2109 | [2] |
LDCM0530 | Nucleophilic fragment 28a | MDA-MB-231 | C425(0.81); C22(0.71) | LDD2123 | [2] |
LDCM0534 | Nucleophilic fragment 30a | MDA-MB-231 | C425(0.68); C22(0.61) | LDD2127 | [2] |
LDCM0536 | Nucleophilic fragment 31 | MDA-MB-231 | C425(1.35) | LDD2129 | [2] |
LDCM0542 | Nucleophilic fragment 37 | MDA-MB-231 | C425(0.79) | LDD2135 | [2] |
LDCM0543 | Nucleophilic fragment 38 | MDA-MB-231 | C425(1.08); C22(1.12) | LDD2136 | [2] |
LDCM0544 | Nucleophilic fragment 39 | MDA-MB-231 | C22(0.81) | LDD2137 | [2] |
LDCM0211 | Nucleophilic fragment 3b | MDA-MB-231 | C425(1.19) | LDD1700 | [2] |
LDCM0546 | Nucleophilic fragment 40 | MDA-MB-231 | C425(0.75); C22(0.62) | LDD2140 | [2] |
LDCM0552 | Nucleophilic fragment 6a | MDA-MB-231 | C425(0.61); C22(0.58) | LDD2146 | [2] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Other
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Pyridoxal Phosphate | Small molecular drug | DB00114 |
Preclinical
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
2-amino-4-[3-hydroxyphenyl]-4-hydroxybutanoic Acid | Small molecular drug | D17TRG | |||
S-(2-aminophenyl)-l-cysteine S,S-dioxide | Small molecular drug | D6QA4N |
Investigative
References